F.D.A. Clears Sunscreen Ingredient Long Used in Europe and Asia
Sentiment Mix
Geography
Expert Signals
CBS News - Top Stories
source • 2 mentions
ABC News - Top Stories
source • 1 mention
New York Times - Home Page
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
Jon LaPook has more details.
Supported by 1 story
FDA green-lights 1st new sunscreen ingredient in years.
Supported by 1 story
The Food and Drug Administration is green-lighting a new sunscreen ingredient.
Supported by 1 story
A sunscreen ingredient that's been available in Europe, Japan and South Korea for years has finally been approved by the FDA for sale in the U.S.
Supported by 1 story
Summary
**** The Food and Drug Administration (FDA) has cleared a new sunscreen ingredient, bemotrizinol, which has been used for years in Europe and Asia. Dermatologists say it offers advantages over other compounds currently on the market. **
Why It Matters
This development could lead to
Related Events
World-first: therapy to make cells young again given to a person - Nature
Uncategorized • 6/9/2026
Mission RCMP target drug website reportedly selling to youth - Castanet
Uncategorized • 6/10/2026
Bikini crackdown at cruise destinations may surprise summer travelers
Uncategorized • 6/9/2026
Donanemab Shows Durable Amyloid Clearance and Consistent Safety in Early-Start Patients - NeurologyLive
Security • 6/9/2026
After FCAS demise, Germany’s options include ordering more F-35 warplanes - Defense News
Uncategorized • 6/9/2026